Arcturus Therapeutics Holdings (ARCT) Shares Issued: 2018-2025
Historic Shares Issued for Arcturus Therapeutics Holdings (ARCT) over the last 5 years, with Sep 2025 value amounting to $640,000.
- Arcturus Therapeutics Holdings' Shares Issued rose 5718.18% to $640,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 79.09%. This contributed to the annual value of $4.7 million for FY2024, which is 77.51% up from last year.
- Arcturus Therapeutics Holdings' Shares Issued amounted to $640,000 in Q3 2025, which was up 133.58% from $274,000 recorded in Q2 2025.
- Over the past 5 years, Arcturus Therapeutics Holdings' Shares Issued peaked at $2.4 million during Q2 2024, and registered a low of $11,000 during Q3 2024.
- In the last 3 years, Arcturus Therapeutics Holdings' Shares Issued had a median value of $640,000 in 2025 and averaged $935,444.
- As far as peak fluctuations go, Arcturus Therapeutics Holdings' Shares Issued crashed by 99.91% in 2021, and later surged by 5,718.18% in 2025.
- Arcturus Therapeutics Holdings' Shares Issued (Quarterly) stood at $230,000 in 2021, then surged by 233.91% to $768,000 in 2022, then soared by 74.87% to $1.3 million in 2023, then slumped by 90.02% to $134,000 in 2024, then spiked by 5,718.18% to $640,000 in 2025.
- Its Shares Issued was $640,000 in Q3 2025, compared to $274,000 in Q2 2025 and $195,000 in Q1 2025.